thalidomide has been researched along with deoxyguanosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, H; Hyakkoku, K; Izuta, H; Nakajima, Y; Shibata, N; Shimazawa, M; Yamamoto, T | 1 |
| Gonçalves, LL; Lee, CJ; Wells, PG | 1 |
2 other study(ies) available for thalidomide and deoxyguanosine
| Article | Year |
|---|---|
Thalidomide protects against ischemic neuronal damage induced by focal cerebral ischemia in mice.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Analysis of Variance; Animals; Blood Pressure; Cell Death; Cells, Cultured; Cerebral Infarction; Deoxyguanosine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Free Radical Scavengers; Heart Rate; In Situ Nick-End Labeling; In Vitro Techniques; Infarction, Middle Cerebral Artery; Lipid Peroxidation; Male; Mice; Nervous System Diseases; Neuroprotective Agents; Retinal Ganglion Cells; Thalidomide; Time Factors; Tumor Necrosis Factor-alpha | 2009 |
Embryopathic effects of thalidomide and its hydrolysis products in rabbit embryo culture: evidence for a prostaglandin H synthase (PHS)-dependent, reactive oxygen species (ROS)-mediated mechanism.
Topics: 5,8,11,14-Eicosatetraynoic Acid; 8-Hydroxy-2'-Deoxyguanosine; Animals; Aspirin; Brain; Deoxyguanosine; Embryo, Mammalian; Female; Hydrolysis; Limb Buds; Male; Molecular Structure; Oxidation-Reduction; Prostaglandin-Endoperoxide Synthases; Rabbits; Reactive Oxygen Species; Teratogens; Thalidomide; Tissue Culture Techniques | 2011 |